Kjeldsberg et al., 1974 - Google Patents
Spurious thrombocytopeniaKjeldsberg et al., 1974
- Document ID
- 11982806520367290318
- Author
- Kjeldsberg C
- Hershgold E
- Publication year
- Publication venue
- Jama
External Links
Snippet
Extensive clinical investigation is usually demanded by the report of thrombocytopenia. Therefore, it is important to be aware that, even with automated equipment, low platelet counts may be erroneous due to causes such as giant platelets, platelet agglutinins, and …
- 206010043554 Thrombocytopenia 0 title abstract description 13
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kjeldsberg et al. | Spurious thrombocytopenia | |
Corash et al. | Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure | |
Gröttum et al. | Wiskott—Aldrich Syndrome: Qualitative Platelet Defects and Short Platelet Survival | |
Spaet et al. | Defective platelets in essential thrombocythemia | |
Zinkham et al. | In vitro erythrophagocytosis in acquired hemolytic anemia | |
Johnson et al. | The mechanism of the endothelial supporting function of intact platelets | |
Kunstling et al. | Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH)—a comparison of the complement-sensitive and insensitive populations | |
Solanki et al. | Spurious leukocytosis and thrombocytopenia: A dual phenomenon caused by clumping of platelets in vitro | |
Adelson et al. | Studies on platelets: VI. Demonstration and characterization of a heterologous (Forssman) platelet agglutinin | |
Sweeney et al. | The effect of the platelet count on the aggregation response and adenosine triphosphate release in an impedance lumi-aggregometer | |
Butler | Chronic idiopathic immunoneutropenia | |
Inceman et al. | Essential athrombia | |
Ognean et al. | Transfusion Triggers and therapeutic efficacy in a group of dogs that underwent whole blood therapy | |
Nitshe Jr et al. | SERUM PROTEIN CHANGES IN MYELOGENOUS AND LYMPHOCYTIC LEUKEMIAS AND HODGKIN’S DISEASE | |
Daland et al. | Hematologic observations in bacterial endocarditis: especially the prevalence of histiocytes and the elevation and variation of the white cell count in blood from the ear lobe | |
Ah-Moye et al. | Introduction to haematology and transfusion science | |
Weiss et al. | Functions of the Blood | |
Isenberg et al. | Haematological aspects of systemic lupus erythematosus: a reappraisal using automated methods | |
Arnaud et al. | Function and ultrastructure of transfused, surviving, human platelets in patients with thrombocytopenic complicating disease | |
Effiong et al. | Haematological values in healthy full-term Nigerian newborn infants | |
Kretschmer et al. | Thrombocytopenia-adapted in vitro bleeding test assesses platelet function in thrombocytopenic patients | |
Isbister | Haemotherapy for acute haemorrhage | |
Li et al. | Hemolytic Transfusion Reactions Due to Lea and Leb Antibodies | |
BHUNIA | Teacher's Notes for Semester-IV (Honours) students | |
Sanyal | Clinical pathology a practical manual |